Indication
Mucormycosis
Mucormycosis is a rare, rapidly progressive, and life-threatening opportunistic fungal infection caused by molds within the order Mucorales, most frequently involving species such as *Rhizopus*, *Mucor*, and *Lichtheimia*. Read more about Mucormycosis
5 drugs 4 manufacturers
Drugs that treat it
Common Mucormycosis therapies.
ABELCET (amphotericin B lipid complex)
CRESEMBA (isavuconazonium sulfate)
CRESEMBA (isavuconazonium sulfate)
ABELCET (amphotericin B lipid complex)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMucormycosis is a rare, rapidly progressive, and life-threatening opportunistic fungal infection caused by molds within the order Mucorales, most frequently involving species such as *Rhizopus*, *Mucor*, and *Lichtheimia*.
It predominantly targets vulnerable populations, including individuals with poorly controlled diabetes mellitus (particularly with ketoacidosis), hematologic malignancies, profound neutropenia, solid organ or stem cell transplants, or severe trauma.
The disease most commonly manifests in rhino-orbito-cerebral, pulmonary, cutaneous, or gastrointestinal forms, with the potential for widespread hematogenous dissemination.
Pathophysiologically, it is defined by marked angioinvasion, in which broad, ribbon-like, nonseptate or pauciseptate hyphae penetrate blood vessel walls, precipitating extensive thrombosis, tissue infarction, and rapidly destructive necrosis.
- cdc.gov
Mucormycosis is a rare, rapidly progressive, and life-threatening opportunistic fungal infection caused by molds within the order Mucorales, most frequently involving species such as *Rhizopus*, *Mucor*, and *Lichtheimia* It predominantly targets vulnerable populations, including individuals with poorly controlled diabetes mellitus (particularly with ketoacidosis), hematologic malignancies, profound neutropenia, solid organ or stem cell transplants, or severe trauma
- nih.gov
It predominantly targets vulnerable populations, including individuals with poorly controlled diabetes mellitus (particularly with ketoacidosis), hematologic malignancies, profound neutropenia, solid organ or stem cell transplants, or severe trauma The disease most commonly manifests in rhino-orbito-cerebral, pulmonary, cutaneous, or gastrointestinal forms, with the potential for widespread hematogenous dissemination Pathophysiologically, it is defined by marked angioinvasion, in which broad, ri...
- nih.gov
It predominantly targets vulnerable populations, including individuals with poorly controlled diabetes mellitus (particularly with ketoacidosis), hematologic malignancies, profound neutropenia, solid organ or stem cell transplants, or severe trauma The disease most commonly manifests in rhino-orbito-cerebral, pulmonary, cutaneous, or gastrointestinal forms, with the potential for widespread hematogenous dissemination
- nih.gov
The disease most commonly manifests in rhino-orbito-cerebral, pulmonary, cutaneous, or gastrointestinal forms, with the potential for widespread hematogenous dissemination
- nih.gov
Pathophysiologically, it is defined by marked angioinvasion, in which broad, ribbon-like, nonseptate or pauciseptate hyphae penetrate blood vessel walls, precipitating extensive thrombosis, tissue infarction, and rapidly destructive necrosis
Personalize your experience
Follow Mucormycosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.